166 related articles for article (PubMed ID: 33886022)
21. microRNA-25 Inhibits Cell Apoptosis of Human Gastric Adenocarcinoma Cell Line AGS via Regulating CCNE1 and MYC.
Zhang Y; Peng Z; Zhao Y; Chen L
Med Sci Monit; 2016 Apr; 22():1415-20. PubMed ID: 27120728
[TBL] [Abstract][Full Text] [Related]
22. MiR-25 enhances autophagy and promotes sorafenib resistance of hepatocellular carcinoma via targeting FBXW7.
Feng X; Zou B; Nan T; Zheng X; Zheng L; Lan J; Chen W; Yu J
Int J Med Sci; 2022; 19(2):257-266. PubMed ID: 35165511
[TBL] [Abstract][Full Text] [Related]
23. miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7.
Xu J; Wu W; Wang J; Huang C; Wen W; Zhao F; Xu X; Pan X; Wang W; Zhu Q; Chen L
Oncol Rep; 2017 Feb; 37(2):1052-1058. PubMed ID: 28000899
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
25. FBXW7: a critical tumor suppressor of human cancers.
Yeh CH; Bellon M; Nicot C
Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L
Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160
[TBL] [Abstract][Full Text] [Related]
27. TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer.
Liu X; Ma J; Xu F; Li L
Biomed Pharmacother; 2018 Mar; 99():9-17. PubMed ID: 29324317
[TBL] [Abstract][Full Text] [Related]
28. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
31. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
32. ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.
Chan TS; Cheng LH; Hsu CC; Yang PM; Liao TY; Hsieh HY; Lin PC; HuangFu WC; Chuu CP; Tsai KK
Mol Oncol; 2024 Mar; 18(3):562-579. PubMed ID: 38279565
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.
Han S; Wang L; Sun L; Wang Y; Yao B; Chen T; Liu R; Liu Q
Biomed Pharmacother; 2020 Feb; 122():109754. PubMed ID: 31918285
[TBL] [Abstract][Full Text] [Related]
35. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of miR-92a promotes the tumor growth of osteosarcoma by suppressing F-box and WD repeat-containing protein 7.
Jiang X; Li X; Wu F; Gao H; Wang G; Zheng H; Wang H; Li J; Chen C
Gene; 2017 Mar; 606():10-16. PubMed ID: 28069547
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of miR-106a suppresses migration and invasion and enhances radiosensitivity of hepatocellular carcinoma cells by upregulating FBXW7.
Deng P; Wu Y
Int J Clin Exp Pathol; 2019; 12(4):1184-1193. PubMed ID: 31933933
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
Chen P; Zhao X; Ma L
Mol Cell Biochem; 2013 Nov; 383(1-2):49-58. PubMed ID: 23842624
[TBL] [Abstract][Full Text] [Related]
40. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]